Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03804827 · ClinicalTrials.gov registry record
Sleep Disordered Breathing in Acute Congestive Heart Failure
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 19
- Enrollment target
NCT03804827: Completed study, sponsored by University of California, San Diego.
NCT03804827 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03804827 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The goal of this study is to determine if sleep disordered breathing results in a measurable degree of overnight myocardial stress/injury in patients with acutely decompensated congestive heart failure. A secondary goal is to determine of a period of medical management attenuates this sleep disordered breathing-induced cardiac injury in this patient population.
Primary Outcome
Overnight change in serum troponin concentration PRE vs POST sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2021-08-03 |
What the finished NCT03804827 record still lists
NCT03804827 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03804827 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03804827 about?
NCT03804827 is a clinical study titled "Sleep Disordered Breathing in Acute Congestive Heart Failure". The goal of this study is to determine if sleep disordered breathing results in a measurable degree of overnight myocardial stress/injury in patients with acutely decompensated congestive heart failure. A secondary goal is to determine of a period of medical management attenuates this sleep disorder...
What is the current status of trial NCT03804827?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2019-01-14. Estimated completion is 2021-08-03.
Who is sponsoring clinical trial NCT03804827?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI